For anti-metastasis, IVIG reduced melanoma and sarcoma spread in experimental models by boosting IL-12 and NK cell activity and suppressing MMP-9, also demonstrating anti-angiogenic properties that hinder metastasis development (19, 20). The gene discussed is MMP9; the disease is sarcoma.